The terminology, classifications and staging of neuroendocrine tumors of the pancreas

Kubyshkin V.A.; Kochatkov A.V.; Konstantinova M.M.; Kriger A.G.

doi:https://doi.org/

Kubyshkin V.A.

FGBU "Institut khirurgii im. A.V. Vishnevskogo" Minzdrava Rossii, Moskva

Kochatkov A.V.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Konstantinova M.M.

Institut khirurgii im. A.V. Vishnevskogo Ministerstva zdravookhraneniia i sotsial'nogo razvitiia Rossiĭskoĭ Federatsii

Kriger A.G.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

The terminology, classifications and staging of neuroendocrine tumors of the pancreas

Authors:

Kubyshkin V.A., Kochatkov A.V., Konstantinova M.M., Kriger A.G.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2012;(6): 4‑8

Read: 3128 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kubyshkin VA, Kochatkov AV, Konstantinova MM, Kriger AG. The terminology, classifications and staging of neuroendocrine tumors of the pancreas. Pirogov Russian Journal of Surgery. 2012;(6):4‑8. (In Russ.)

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)

Использование инфографики авторами научных работ

Close metadata

Abstract:

The basic classifications, including the TNM and the WHO's classification of neuroendoctine tumors of the pancreas are highlighted. The WHO's dividing such tumors on G1 and G2 neuroendocrine lesions and G3 neuroendocrine carcinomas is substantiated.

Keywords:

neuroendocrine neoplasias

tumors of the pancreas

TNM

WHO classification

Authors:

Kubyshkin V.A.

FGBU "Institut khirurgii im. A.V. Vishnevskogo" Minzdrava Rossii, Moskva

Kochatkov A.V.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Konstantinova M.M.

Institut khirurgii im. A.V. Vishnevskogo Ministerstva zdravookhraneniia i sotsial'nogo razvitiia Rossiĭskoĭ Federatsii

Kriger A.G.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Close metadata

References:

Abdulkerimov Z.A. "Nefunktsioniruyushchie" neiroendokrinnye opukholi podzheludochnoi zhelezy: Avtoref. dis. ... kand. med nauk. M 2001.
Gurevich L.E. Diagnostika neiroendokrinnykh opukholei zheludochno-kishechnogo trakta. Prakticheskaya onkologiya 2005; 6: 4: 193-201.
Egorov A.V., Kuzin N.M. Voprosy diagnostiki neiroendokrinnykh opukholei podzheludochnoi zhelezy. Prakticheskaya onkologiya 2005; 6: 4: 206-212.
Imyanitov E.N. Epidemiologiya i biologiya neiroendokrinnykh opukholei. Prakticheskaya onkologiya. M 2005; 6: 4: 202-205.
Shchegolev A.I., Paklina O.V., Galil-Ogly G.A. Opukholi podzheludochnoi zhelezy. Arkh pat 2006; Prilozhenie: 1-48.
Arnold R. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. Best Pract & Res Clin Gastroenterol 2005; 19: 4: 491-505.
Bishop A.E., Polak J.M., Facer P. et al. Neuron specific enolase: a common marker for the endocrine cells and innervation of the gut and pancreas. Gastroenterology 1982; 83: 902-915.
Bostan F., Carneiro F., Hruban R., Theise N., (T)eds. WHO Classification of Tumours of the Digestive System. IARC Press Lyon, France 2010.
DeLellis R.A., Lloyd R.V., Heitz P.U., Eng C. (eds) World Health Organization classification of tumours, pathology and genetics of tumours of endocrine organs. IARC Lyon 2004.
Edge S., Byrd D., Carducci M. et al. AJCC Cancer Staging Manual. 7th ed. New York: Springer 2009.
Hochwald S.N., Zee S., Conlon K.C. et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. J Clin Oncol 2002; 20: 2633-2642.
Klimstra D.S., Öberg K., Komminoth P., Bordi C. Non-Functioning Tumors and Microadenomas. Lyon IARC Press 2004.
Kulke M.H., Anthony L.B., Bushnell D.L., de Herder W.W., Goldsmith S.J., Klimstra D.S., Marx S.J., Pasieka J.L., Pommier R.F., Yao J.C., Jensen R.T. NANETS Treatment Guidelines Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas. Pancreas 2010; 39: 735-752.
Lloyd R.V., Wilson B.S. Specific endocrine tissue marker defined by a monoclonal antibody. Science 1983; 222: 628-630.
Marion-Audibert A.M., Barel C., Gouysse G. et al. Low microvessel density is an unfavorable histoprognostic factor in pancreatic endocrine tumors. Gastroenterology 2003; 125: 1094-1104.
Oberg K.E. Gastrointestinal neuroendocrine tumors. Annals of Oncology 21 (Supplement 7) 2010; 72-80.
Rindi G., Klöppel G., Ahlman H. et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449: 395-401.
Rinke A., Muller H.H., Schade-Brittinger C. et al. Placebo-controlled, doubleblind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROM1D Study Group. J Clin Oncol 2009; 27: 4656-4663.
Rode J., Dhillon A.P., Doran J.F. et al. PGP 9.5, a new marker for human neuroendocrine tumors. Histopathology 1985; 9: 147-158.
Soga J., Tazawa K. Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases. Cancer 1971; 28: 4: 990-908.
Solcia E., Kloppel G., Sobin L.H. World Health Organization: International Histological Classification of Tumors: Histological Typing of Endocrine Tumors. Berlin: Springer 2000.
Wiedenmann B., Franke W.W., Kuhn C. et al. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci USA 1986; 83: 3500-3504.